Vanguard Group Inc Veru Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VERU
# of Institutions
104Shares Held
44MCall Options Held
519KPut Options Held
396K-
Adage Capital Partners Gp, L.L.C. Boston, MA11MShares$10.5 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY5.58MShares$5.31 Million0.08% of portfolio
-
Octagon Capital Advisors LP New York, NY3.8MShares$3.61 Million0.42% of portfolio
-
Morgan Stanley New York, NY2.73MShares$2.6 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY2.11MShares$2.01 Million0.83% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $76.1M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....